Curis (CRIS) Amortization of Deferred Charges (2013 - 2019)
Curis (CRIS) reported Amortization of Deferred Charges of $8000.0 for Q1 2019, down 11.11% on a YoY basis from $9000.0 in Q1 2018, and down 20.0% quarter-over-quarter from $10000.0 in Q4 2018.
Curis (CRIS) Amortization of Deferred Charges (2013 - 2019) Analysis & Trends
Curis has reported Amortization of Deferred Charges for 7 years, with the latest figure at $8000.0 in Q1 2019.
- For the quarter ending Q1 2019, Amortization of Deferred Charges fell 11.11% year-over-year to $8000.0; the trailing twelve-month figure through Dec 2019 stood at $8000.0 (down 77.14% YoY), and the FY2019 full-year result was $8000.0, down 77.14% from the prior year.
- Amortization of Deferred Charges for Q1 2019 stood at $8000.0, down from $10000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $119000.0 in Q1 2017, with the low at $7000.0 in Q3 2017.
- Historically, Amortization of Deferred Charges has averaged $17117.6 across 5 years, with a median of $12000.0 in 2015.
- Annual changes were most pronounced in 2017 — Amortization of Deferred Charges jumped 891.67% — and 2018, when it sank 92.44%.
- Curis' Amortization of Deferred Charges stood at $12000.0 in 2015, then changed by 0.0% to $12000.0 in 2016, then retreated by 25.0% to $9000.0 in 2017, then rose by 11.11% to $10000.0 in 2018, then slipped by 20.0% to $8000.0 in 2019.
- The last three Amortization of Deferred Charges figures came in at $8000.0 (Q1 2019), $10000.0 (Q4 2018), and $9000.0 (Q3 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 8,000.00 |
| Mar 31, 2019 | 8,000.00 |
| Dec 31, 2018 | 10,000.00 |
| Dec 31, 2018 | 10,000.00 |
| Sep 30, 2018 | 9,000.00 |
| Sep 30, 2018 | 9,000.00 |
| Jun 30, 2018 | 7,000.00 |
| Jun 30, 2018 | 7,000.00 |
| Mar 31, 2018 | 9,000.00 |
| Mar 31, 2018 | 9,000.00 |
| Dec 31, 2017 | 9,000.00 |
| Dec 31, 2017 | 9,000.00 |
| Sep 30, 2017 | 7,000.00 |
| Sep 30, 2017 | 7,000.00 |
| Jun 30, 2017 | 9,000.00 |
| Jun 30, 2017 | 9,000.00 |
| Mar 31, 2017 | 119,000.00 |
| Mar 31, 2017 | 119,000.00 |
| Dec 31, 2016 | 12,000.00 |
| Dec 31, 2016 | 12,000.00 |